Go Pro

Venture Life Group (VLG) Competitors

Venture Life Group logo
GBX 66 0.00 (0.00%)
As of 11:59 AM Eastern

VLG vs. BXP, ANCR, BVXP, EAH, and ORPH

Should you buy Venture Life Group stock or one of its competitors? Venture Life Group's main competitors and comparable companies include Beximco Pharmaceuticals (BXP), Animalcare Group (ANCR), Bioventix (BVXP), ECO Animal Health Group (EAH), and Open Orphan (ORPH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Venture Life Group compare to Beximco Pharmaceuticals?

Beximco Pharmaceuticals (LON:BXP) and Venture Life Group (LON:VLG) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings.

Beximco Pharmaceuticals has a beta of 0.248, meaning that its stock price is 75% less volatile than the broader market. Comparatively, Venture Life Group has a beta of 0.217, meaning that its stock price is 78% less volatile than the broader market.

Beximco Pharmaceuticals has higher revenue and earnings than Venture Life Group. Beximco Pharmaceuticals is trading at a lower price-to-earnings ratio than Venture Life Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beximco Pharmaceuticals£53.93B0.00£970.84B£1.94 thousand0.03
Venture Life Group£35.17M2.27£747.21K£4.3715.10

In the previous week, Venture Life Group had 1 more articles in the media than Beximco Pharmaceuticals. MarketBeat recorded 1 mentions for Venture Life Group and 0 mentions for Beximco Pharmaceuticals. Beximco Pharmaceuticals' average media sentiment score of 0.30 beat Venture Life Group's score of 0.00 indicating that Beximco Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
Beximco Pharmaceuticals Neutral
Venture Life Group Neutral

0.3% of Beximco Pharmaceuticals shares are held by institutional investors. Comparatively, 21.9% of Venture Life Group shares are held by institutional investors. 4.2% of Beximco Pharmaceuticals shares are held by insiders. Comparatively, 7.5% of Venture Life Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Venture Life Group has a net margin of 17.42% compared to Beximco Pharmaceuticals' net margin of 16.76%. Beximco Pharmaceuticals' return on equity of 11.99% beat Venture Life Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Beximco Pharmaceuticals16.76% 11.99% 6.97%
Venture Life Group 17.42%7.82%1.56%

Summary

Beximco Pharmaceuticals beats Venture Life Group on 7 of the 13 factors compared between the two stocks.

How does Venture Life Group compare to Animalcare Group?

Venture Life Group (LON:VLG) and Animalcare Group (LON:ANCR) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.

21.9% of Venture Life Group shares are held by institutional investors. Comparatively, 14.3% of Animalcare Group shares are held by institutional investors. 7.5% of Venture Life Group shares are held by company insiders. Comparatively, 30.1% of Animalcare Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Venture Life Group has a net margin of 17.42% compared to Animalcare Group's net margin of 5.70%. Venture Life Group's return on equity of 7.82% beat Animalcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Venture Life Group17.42% 7.82% 1.56%
Animalcare Group 5.70%4.46%2.97%

In the previous week, Venture Life Group had 1 more articles in the media than Animalcare Group. MarketBeat recorded 1 mentions for Venture Life Group and 0 mentions for Animalcare Group. Venture Life Group's average media sentiment score of 0.00 equaled Animalcare Group'saverage media sentiment score.

Company Overall Sentiment
Venture Life Group Neutral
Animalcare Group Neutral

Animalcare Group has higher revenue and earnings than Venture Life Group. Venture Life Group is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Venture Life Group£35.17M2.27£747.21K£4.3715.10
Animalcare Group£89.11M2.60£36.55M£7.3045.89

Venture Life Group has a beta of 0.217, indicating that its share price is 78% less volatile than the broader market. Comparatively, Animalcare Group has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market.

Summary

Animalcare Group beats Venture Life Group on 8 of the 12 factors compared between the two stocks.

How does Venture Life Group compare to Bioventix?

Venture Life Group (LON:VLG) and Bioventix (LON:BVXP) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings, valuation and media sentiment.

In the previous week, Venture Life Group had 1 more articles in the media than Bioventix. MarketBeat recorded 1 mentions for Venture Life Group and 0 mentions for Bioventix. Venture Life Group's average media sentiment score of 0.00 equaled Bioventix'saverage media sentiment score.

Company Overall Sentiment
Venture Life Group Neutral
Bioventix Neutral

Venture Life Group has a beta of 0.217, meaning that its share price is 78% less volatile than the broader market. Comparatively, Bioventix has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market.

Bioventix has a net margin of 59.30% compared to Venture Life Group's net margin of 17.42%. Bioventix's return on equity of 65.83% beat Venture Life Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Venture Life Group17.42% 7.82% 1.56%
Bioventix 59.30%65.83%54.07%

Bioventix has lower revenue, but higher earnings than Venture Life Group. Bioventix is trading at a lower price-to-earnings ratio than Venture Life Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Venture Life Group£35.17M2.27£747.21K£4.3715.10
Bioventix£12.54M7.08£8.12M£140.5212.10

21.9% of Venture Life Group shares are held by institutional investors. Comparatively, 20.6% of Bioventix shares are held by institutional investors. 7.5% of Venture Life Group shares are held by company insiders. Comparatively, 6.2% of Bioventix shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Bioventix beats Venture Life Group on 7 of the 12 factors compared between the two stocks.

How does Venture Life Group compare to ECO Animal Health Group?

Venture Life Group (LON:VLG) and ECO Animal Health Group (LON:EAH) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership, media sentiment and risk.

Venture Life Group has a net margin of 17.42% compared to ECO Animal Health Group's net margin of 2.50%. Venture Life Group's return on equity of 7.82% beat ECO Animal Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Venture Life Group17.42% 7.82% 1.56%
ECO Animal Health Group 2.50%2.55%2.14%

Venture Life Group has a beta of 0.217, indicating that its stock price is 78% less volatile than the broader market. Comparatively, ECO Animal Health Group has a beta of 0.71863484, indicating that its stock price is 28% less volatile than the broader market.

21.9% of Venture Life Group shares are owned by institutional investors. Comparatively, 40.8% of ECO Animal Health Group shares are owned by institutional investors. 7.5% of Venture Life Group shares are owned by company insiders. Comparatively, 11.3% of ECO Animal Health Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

ECO Animal Health Group has a consensus price target of GBX 160, indicating a potential upside of 60.64%. Given ECO Animal Health Group's stronger consensus rating and higher probable upside, analysts clearly believe ECO Animal Health Group is more favorable than Venture Life Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Venture Life Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
ECO Animal Health Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

ECO Animal Health Group has higher revenue and earnings than Venture Life Group. Venture Life Group is trading at a lower price-to-earnings ratio than ECO Animal Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Venture Life Group£35.17M2.27£747.21K£4.3715.10
ECO Animal Health Group£87.53M0.76£1.05M£3.1531.62

In the previous week, Venture Life Group had 1 more articles in the media than ECO Animal Health Group. MarketBeat recorded 1 mentions for Venture Life Group and 0 mentions for ECO Animal Health Group. Venture Life Group's average media sentiment score of 0.00 equaled ECO Animal Health Group'saverage media sentiment score.

Company Overall Sentiment
Venture Life Group Neutral
ECO Animal Health Group Neutral

Summary

ECO Animal Health Group beats Venture Life Group on 10 of the 15 factors compared between the two stocks.

How does Venture Life Group compare to Open Orphan?

Venture Life Group (LON:VLG) and Open Orphan (LON:ORPH) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, valuation, earnings, institutional ownership and dividends.

Venture Life Group has higher revenue and earnings than Open Orphan.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Venture Life Group£35.17M2.27£747.21K£4.3715.10
Open Orphan£34.71M0.00N/AN/AN/A

In the previous week, Venture Life Group had 1 more articles in the media than Open Orphan. MarketBeat recorded 1 mentions for Venture Life Group and 0 mentions for Open Orphan. Venture Life Group's average media sentiment score of 0.00 equaled Open Orphan'saverage media sentiment score.

Company Overall Sentiment
Venture Life Group Neutral
Open Orphan Neutral

Venture Life Group has a net margin of 17.42% compared to Open Orphan's net margin of 0.00%. Venture Life Group's return on equity of 7.82% beat Open Orphan's return on equity.

Company Net Margins Return on Equity Return on Assets
Venture Life Group17.42% 7.82% 1.56%
Open Orphan N/A N/A N/A

21.9% of Venture Life Group shares are held by institutional investors. 7.5% of Venture Life Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Venture Life Group beats Open Orphan on 8 of the 8 factors compared between the two stocks.

Get Venture Life Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for VLG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VLG vs. The Competition

MetricVenture Life GroupPharmaceuticals IndustryHealthcare SectorLON Exchange
Market Cap£79.80M£12.66B£7.40B£2.92B
Dividend Yield0.09%2.61%2.53%6.17%
P/E Ratio15.10782.99272.19367.32
Price / Sales2.27758.69631.4983,741.35
Price / Cash6.4096.4679.8927.89
Price / Book1.1212.0013.147.02
Net Income£747.21K£2.83B£3.47B£5.89B
7 Day Performance3.77%2.04%1.38%0.89%
1 Month Performance-4.76%6.08%8.62%3.27%
1 Year Performance17.07%7.74%25.90%22.28%

Venture Life Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VLG
Venture Life Group
N/AGBX 66
flat
N/A+13.5%£79.80M£35.17M15.10165
BXP
Beximco Pharmaceuticals
N/AGBX 56.70
flat
N/A+7.2%£252.95M£53.93B0.035,500
ANCR
Animalcare Group
N/AGBX 335
flat
N/AN/A£231.30M£89.11M45.89220
BVXP
Bioventix
N/AGBX 1,577
+2.5%
N/A-31.2%£82.40M£12.54M11.2212
EAH
ECO Animal Health Group
N/AGBX 103
+2.8%
GBX 160
+55.3%
+37.4%£68.72M£87.53M32.70234

Related Companies and Tools


This page (LON:VLG) was last updated on 8/26/2026 by MarketBeat.com Staff.
From Our Partners